Clinical Research Directory

Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma

Sponsor: Kazutaka Uchida

Summary

COMPLEMENT study (ChrOnic subdural hematoMa Patients suppLemented with Embolization of Middle mENingeal artery Trial) is a prospective, open label, blinded endpoint (PROBE), Japanese, two-arm, randomized, controlled, post-market study to assess the efficacy and safety of middle meningeal artery embolization for chronic subdural hematoma.

Official title: Randomized Clinical Trial of Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma (COMPLEMENT Study)

Key Details

Conditions

Interventions

Locations (1)